Ignite Creation Date:
2024-05-06 @ 2:59 PM
Last Modification Date:
2024-10-26 @ 1:40 PM
Study NCT ID:
NCT04481113
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-07
First Post:
2020-07-17
Brief Title:
Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer
Sponsor:
OHSU Knight Cancer Institute
Organization:
OHSU Knight Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-07-17
First Submit QC Date:
July 20 2020
Study First Post Date:
2020-07-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-15
Last Update Post Date:
2024-05-07
Last Update Post Date Type:
ACTUAL